ストックスクリーナーアプリを入手
5.45
3.22%
0.17
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms market - MarketWatch
Inovio Pharmaceuticals (LTS:0A43) Probability of Financial Distress (%) : 0.27% (As of Oct. 30, 2024) - GuruFocus.com
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Brokerages Set Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Target Price at $43.80 - MarketBeat
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP - StockTitan
Indo-Asian News Service - IANS India Pvt Ltd
Global DNA Nanotechnology Market Future Market Projections: - openPR
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Update - MarketBeat
Inovio Pharmaceuticals (LTS:0A43) Change In Prepaid Assets : $-2.12 Mil (TTM As of Jun. 2024) - GuruFocus.com
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2011; Promotes Niranjan Y. Sardesai as Chief Operating Officer from Senior Vice President Research and Development - Marketscreener.com
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Covid-19 Vaccine Market Industry Survey Research Report 2032 – Top Player as Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, Codagenix – Cauverynews - Cauverynews
Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
Inovio Pharmaceuticals, Inc. Announces Leadership Appointments - Marketscreener.com
INOVIO Announces Equity Grants for New Employees Under 2022 Inducement Plan - MSN
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts - Benzinga
Inovio Pharmaceuticals (NASDAQ:INO) Price Target Lowered to $7.00 at Royal Bank of Canada - MarketBeat
INOVIO Reports Inducement Grants Under Inducement Plan - Marketscreener.com
INOVIO to Present at Upcoming Scientific Conferences - Marketscreener.com
Inovio Pharmaceuticals: Takes Another Torpedo But Keeps On Sailing - Seeking Alpha
Inovio Pharmaceuticals' SWOT analysis: stock faces challenges amid pipeline potential - Investing.com
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives $44.00 Average PT from Analysts - MarketBeat
Inari medical director Hoffman sells over $1.8m in company stock - Investing.com
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update - MarketBeat
INVO Bioscience (NASDAQ:INVO) Stock Price Down 1.7% - Defense World
INOVIO to Present at Upcoming Scientific Conference - Lelezard
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 - sharewise
Page 2 | INOVIO PHARMACEUTICALS INC Trade Ideas — GETTEX:GBMB - TradingView
Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch
Inovio Pharmaceuticals Inc. stock rises Tuesday, still underperforms market - MarketWatch
1.08%
1.43%
大文字化:
|
ボリューム (24 時間):